期刊文献+

肝癌细胞来源的exosomes提取方法的改进及电镜观察 被引量:3

ISOLATION METHOD IMPROVEMENT OF EXOSOMES DERIVED FROM HEPATOCARCINOMA CELL AND OBSERVATION WITH ELECTRON MICROSCOPE
下载PDF
导出
摘要 目的:分离提纯两种肝癌细胞HepG2细胞和Hep3B细胞来源的exosomes,并在透射电镜下观察exosomes的形态特征,为肿瘤免疫治疗寻找肿瘤新抗原提供实验材料。方法:采用离心超滤联合蔗糖密度梯度离心等方法分离出HepG2和Hep3B细胞释放exosomes,经透射电镜观察其超微结构。结果:HepG2和Hep3B细胞分泌释放的exosomes为直径50-100nm的膜性微囊结构,圆形或椭圆形,腔内为低电子密度成分。结论:离心超滤和蔗糖密度梯度离心法分离提纯exosomes方法是较为简便高效,对肿瘤细胞培养上清提纯exosomes而言具有可行性。 Objective:Isolating and purifing the exosomes which were derived from HepG2 cell and Hep3 B ceU to investigate the possibility of using these exosomes as a kind of tumor vaccine. Methods: Exosomes were purified by ultrafiltration centrifugation and sucrose gradient ultracentrifugation, and then observed their ultrastructures by electron microscopy. Results:Transmission electron microscopy revealed that the exosomes from HepG2 cell and Hep3B cell culture supematants were 50 to 100nm membrane vesicles. They were round or elliptic in shape. Cavum had low electrondensity components. Conclusion:Uhrafiltration centrifugation technique is a convenient and useful method for isolating exosomes, and it can be used to purify tumor cell-secreted exosomes.
出处 《内蒙古医学院学报》 2008年第6期424-426,共3页 Acta Academiae Medicinae Neimongol
基金 首都医学发展科研基金(2005-3086)
关键词 EXOSOMES HEPG2细胞 HEP3B细胞 透射电镜 exosomes HepG2 cell Hep3 B cell transmission electron microscope
  • 相关文献

参考文献9

  • 1Wolfers J, Lozier A, Raposo G, et al. Tumor - derived exosomes are a source of shared tumor rejection antigens for CTL cross - priming[J]. Nat Med,2001 ;7(3) :297 -303
  • 2Thery C, Zitvogel L, Amigorena S. Exosomes : Composition, biogenesis and function [ J ]. Nat Rev Immunol, 2002 ; 2 (5) :569-579
  • 3Bard MP,Hegmans JP,Hemms A,et al. Proteomie analysis of exosomes isolated from human malignant pleural effusions [ J ]. Am J Respir Cell Mol Biol, 2004 ; 31 ( 1 ) : 114 - 121
  • 4Clayton A, Courta J, Navabi H, et al. Analysis of antigen presenting cell derived exosomes ,based on immuno - magnetic isolation and flow cytometry [ J ]. J Immunol Methods, 2001 ;247(3) :163 - 174
  • 5Henry GL, Metha - Damani A, Patel S, et al. Production and characterization of clinical grade exosomes derived from dendritic cells [ J ]. J Immunol Methods, 2002; 270 (2) :211 -226
  • 6Mignot G, Roux S,Thery C, et al. Prospects for exosomes in immunotherapy of cancer [ J ]. J Cell Mol Med, 2006 ; 10 (2) :376 -388
  • 7Zitvogel L, Regnauh A, Lozier A, et al. Eradication of established murine tumors using a novel cell free vaccine: dendritic cell derived exosomes [ J ]. Natmed, 1998 ; 4 ( 5 ) : 594 - 600
  • 8Hao S, Moyana T, Xiang J. Review: cancer immunotherapy by exosomes -based vaccines [ J ]. Cancer Biother Radiopharm,2007 ; 22 ( 5 ) : 692 - 703
  • 9Keller S, Sanderson MP, Stoeck A, et al. Exosomes : from biogenesis and secretion to biological function [ J ]. Immunol Lett,2006 ;107(2) :102 - 108

同被引文献26

  • 1郝长来,唐克晶,陈森,邢海燕,王敏,王建祥.5-氮杂脱氧胞苷增强苯丁酸钠对Kasumi-1细胞的诱导分化和凋亡作用[J].中华肿瘤杂志,2005,27(3):148-151. 被引量:8
  • 2Wolfers J, Lozier A, Raposo G, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med, 2001, 7:297-303.
  • 3Natsume A, Wakabayashi T, Tsujimura K, et al. The DNA demethylating agent 5-aza-2'-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma. Int J Cancer, 2008, 122 : 2542-2453.
  • 4Serrano A, Tanzarella S, Lionello I, et al. Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment. Int J Cancer, 2001, 94:243-251.
  • 5Cho JA, Lee YS, Kim SH, et al. MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models. Cancer Lett, 2009, 275:256- 265.
  • 6Yu X, Harris SL, Levine AJ. The regulation of exosome secretion : a novel function of the p53 protein. Cancer Res, 2006, 66:4795- 4801.
  • 7Li XB, Zhang ZR, Schluesener HJ. Role of exosomes in immune regulation. J Cell Mol Med,2006,10(2) :364 -375.
  • 8Clayton A, Mitchell JP, et al. Human Tumor - Derived Exosomes Selectively ImpairLymphocyte Responses to Interleukin -2. Cancer Res, 2007,67 ( 15 ) :7458 - 7466.
  • 9: Taylor DD, Gercel - Taylor C. Tumour - derived exosomes and their role in cancer - associated Tcell signaling defects. Br J Cancer,2005,92:305 -311.
  • 10Yang Y, Xiu F, Cai Z, et al. Increased induction of antitumor response by exosomes derived from interleukin - 2 gene - modified tumor cell. J Cancer Res Clin Oncol,2007,133 (6) :389 - 399.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部